WSTAM
CTSO icon

Wilbanks Smith & Thomas Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,800
Closed -$101K – 554
2018
Q3 		$101K Buy
+7,800
New +$97.8K 0.01% 538

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CTSO Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Cytosorbents Corp (CTSO) in Q4 2018, closing a stake of 7,800 shares — an estimated $101K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CTSO in Q3 2018 and held it in 1 quarter. The position peaked at $101K in Q3 2018. 85 funds tracked by Wall St. Rank hold CTSO as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Cytosorbents Corp position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 7,800 Cytosorbents Corp shares in Q4 2018, an estimated $101K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Cytosorbents Corp in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Cytosorbents Corp position peaked at $101K in Q3 2018.
  • 85 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.